ZB
AMED

Zions Bancorporation’s Amedisys AMED Stock Holding History

Zions Bancorporation’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16
Closed -$2K – 922
2022
Q2 		$2K Sell
16
-6
-27% -$767 ﹤0.01% 959
2022
Q1 		$4K Buy
+22
New +$3.29K ﹤0.01% 977
2018
Q4 		– Sell
-10
Closed -$1K – 492
2018
Q3 		$1K Buy
+10
New +$1.1K ﹤0.01% 731

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Zions Bancorporation's AMED Position: Q3 2022 in Review

Zions Bancorporation sold out of Amedisys (AMED) in Q3 2022, closing a stake of 16 shares — an estimated $2K sold.

Zions Bancorporation first reported a position in AMED in Q3 2018 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Zions Bancorporation reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Zions Bancorporation sold 16 Amedisys shares in Q3 2022, an estimated $2K.
  • Zions Bancorporation first reported a position in Amedisys in Q3 2018 and held it in 3 quarters.
  • Zions Bancorporation's Amedisys position peaked at $4K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Zions Bancorporation's 13F filing for Q3 2022, filed 8 Nov 2022.